CME MULTIMEDIA ACTIVITIES

June 2010
CME The Foundation Role of Beta Blockers Across the Cardiovascular Disease Spectrum: A Year 2009 Update
Presenters: Henry R. Black, MD, Barry H. Greenberg, MD, and Michael A. Weber, MD

As the incidence of cardiovascular disease (CVD) continues to increase, it is critical for clinicians to be informed on advances in the management of CVD and its risk factors. As a class, beta blockers have proven effective in the management of hypertension and heart failure but may be underutilized, in part, due to concerns about tolerability. It is clear, however, that the newer vasodilatory, cardioselective beta blockers provide efficacy across the spectrum of CVD while lacking the adverse side-effect profile of the older, nonvasodilatory agents. It is the aim of this interactive CME program to evaluate the evidence and define the role of these newer agents while examining the implication of their use to improve outcomes.

Commercial Support: Forest Laboratories, Inc.
Review and Sponsorship: This multimedia activity was peer reviewed by The American Journal of Medicine and jointly sponsored by American Society of Hypertension and Health Education Alliance, Inc.
 

March 2010
CME Managing Gout in the Primary Care Setting: What You and Your Patients Need to Know
Presenters: Paul Doghramji, MD, FAAFP, N. Lawrence Edwards, MD, and Joan McTigue, MS, PA-C

In light of the fact that 70% of gout patients are managed in a primary care office setting, it is critical that healthcare professionals understand how to diagnose, manage, and effectively communicate with their patients about the disease and the importance of appropriate management. It is the aim of this CE activity to provide information that will assist health care providers to overcome obstacles and improve clinical outcomes for their patients with gout. Specifically, information will be provided on differential diagnosis, when and how to treat (including recognizing conditions that will promote or indicate progression), the proper use of existing medications to treat acute and chronic gout, how to communicate with and educate patients to maximize patient adherence, promote lifestyle changes and effective monitoring, and recent advances in the understanding of gout and its treatment.

Commercial Support: Takeda Pharmaceuticals North America
Review and Sponsorship: This multimedia activity was peer reviewed by The American Journal of Medicine and jointly sponsored by Purdue University School of Pharmacy and Health Education Alliance, Inc.
 

January 2010
CME Fibromyalgia Syndrome: Practical Strategies For Improving Diagnosis and Patient Outcomes
Presenters: Lesley M. Arnold, MD, and Daniel J. Clauw, MD

This educational activity provides clinicians with the tools necessary to differentiate fibromyalgia syndrome from other chronic pain conditions through a review of recent clinical data and an application of an advanced understanding of pain pathways. Strategies to manage patients with co-morbid conditions are explored with an emphasis on the importance of a multidisciplinary approach to patient care.

Commercial Support: Forest Laboratories, Inc.
Review and Sponsorship: This multimedia activity was peer reviewed by The American Journal of Medicine and jointly sponsored by Purdue University School of Pharmacy and Health Education Alliance, Inc.